IL-22 defines a novel immune pathway of antifungal resistance

The role of IL-17 and Th17 cells in immunity vs. pathology associated with the human commensal Candida albicans remains controversial. Both positive and negative effects on immune resistance have been attributed to IL-17/Th17 in experimental candidiasis. In this study, we provide evidence that IL-22, which is also produced by Th17 cells, has a critical, first-line defense in candidiasis by controlling the growth of infecting yeasts as well as by contributing to the host's epithelial integrity in the absence of acquired Th1-type immunity. The two pathways are reciprocally regulated, and IL-22 is upregulated under Th1 deficiency conditions and vice versa. Whereas both IL-17A and F are dispensable for antifungal resistance, IL-22 mediates protection in IL-17RA-deficient mice, in which IL-17A contributes to disease susceptibility. Thus, our findings suggest that protective immunity to candidiasis is made up of a staged response involving an early, IL-22-dominated response followed by Th1/Treg reactivity that will prevent fungal dissemination and supply memory.

[1]  C. Tato,et al.  Reconciling id, ego, and superego within interleukin‐23 , 2008, Immunological reviews.

[2]  Francesco Bistoni,et al.  Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts. , 2003, Current opinion in microbiology.

[3]  G. Walz,et al.  Sensitive cilia set up the kidney , 2007, Nature Medicine.

[4]  J. Vincent,et al.  Potential risk factors for infection with Candida spp. in critically ill patients. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  Shinichiro Sawa,et al.  Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. , 2008, Immunity.

[6]  W. Paul,et al.  Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome , 2008, Nature.

[7]  M. Netea,et al.  Severely impaired IL‐12/IL‐18/IFNγ axis in patients with hyper IgE syndrome , 2005, European journal of clinical investigation.

[8]  C. Tato,et al.  Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22 , 2009, The Journal of experimental medicine.

[9]  R. Calderone.  Candida and candidiasis. , 2012 .

[10]  J. Alcorn,et al.  Requirement of IL-17RA in Con A Induced Hepatitis and Negative Regulation of IL-17 Production in Mouse T Cells , 2008, The Journal of Immunology.

[11]  W. Leonard,et al.  Cytokine mediators of Th17 function , 2009, European Journal of Immunology.

[12]  Francesco Bistoni,et al.  Functional yet Balanced Reactivity to Candida albicans Requires TRIF, MyD88, and IDO-Dependent Inhibition of Rorc1 , 2007, The Journal of Immunology.

[13]  J. Ring,et al.  Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. , 2008, The Journal of investigative dermatology.

[14]  H. Spits,et al.  Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? , 2009, Nature Reviews Immunology.

[15]  Andreas Diefenbach,et al.  RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22–producing NKp46+ cells , 2009, Nature Immunology.

[16]  M. Fei,et al.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.

[17]  Francesco Bistoni,et al.  IL‐23 and the Th17 pathway promote inflammation and impair antifungal immune resistance , 2007, European journal of immunology.

[18]  Ting Xu,et al.  Structure of insect-cell-derived IL-22. , 2005, Acta crystallographica. Section D, Biological crystallography.

[19]  B. Becher,et al.  IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. , 2008, The Journal of clinical investigation.

[20]  A. Mencacci,et al.  CD4+ T-helper-cell responses in mice with low-level Candida albicans infection , 1996, Infection and immunity.

[21]  S. Tangye,et al.  Defi ciency of Th 17 cells in hyper IgE syndrome due to mutations in STAT 3 Cindy , 2008 .

[22]  J. Kolls,et al.  Cytokine-mediated regulation of antimicrobial proteins , 2008, Nature Reviews Immunology.

[23]  L. Boon,et al.  Lack of Toll IL-1R8 Exacerbates Th17 Cell Responses in Fungal Infection1 , 2008, The Journal of Immunology.

[24]  R. D. Hatton,et al.  Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.

[25]  S. Sa,et al.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens , 2008, Nature Medicine.

[26]  D. Hogan,et al.  Fungal--bacterial interactions: a mixed bag of mingling microbes. , 2006, Current opinion in microbiology.

[27]  K. Asadullah,et al.  IL-22 increases the innate immunity of tissues. , 2004, Immunity.

[28]  L. Fouser,et al.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. , 2008, The Journal of clinical investigation.

[29]  Hong Tang,et al.  Adaptive immune cells temper initial innate responses , 2007, Nature Medicine.

[30]  Arturo Casadevall,et al.  Accidental Virulence, Cryptic Pathogenesis, Martians, Lost Hosts, and the Pathogenicity of Environmental Microbes , 2007, Eukaryotic Cell.

[31]  P. Puccetti,et al.  Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. , 2006, Trends in microbiology.

[32]  S. Gaffen,et al.  Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis , 2009, The Journal of experimental medicine.

[33]  Gérard Eberl,et al.  In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells , 2008, The Journal of experimental medicine.

[34]  T. Mcclanahan,et al.  IL-23 Enhances the Inflammatory Cell Response in Cryptococcus neoformans Infection and Induces a Cytokine Pattern Distinct from IL-121 , 2006, The Journal of Immunology.

[35]  A. De Luca,et al.  IL-17 and Therapeutic Kynurenines in Pathogenic Inflammation to Fungi1 , 2008, The Journal of Immunology.

[36]  J. Farber,et al.  Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice , 2009, PLoS pathogens.

[37]  S. Tangye,et al.  Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 , 2008, The Journal of experimental medicine.

[38]  Jianfei Yang,et al.  Epstein‐Barr virus‐induced gene 3 negatively regulates IL‐17, IL‐22 and RORγt , 2008, European journal of immunology.

[39]  L. Fouser,et al.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.

[40]  A. Casadevall,et al.  Rethinking T cell immunity in oropharyngeal candidiasis , 2009, The Journal of experimental medicine.

[41]  J. Kolls,et al.  Interleukin-17 A induces bicarbonate secretion in normal human bronchial epithelial cells , 2009 .

[42]  C. Elson,et al.  Late developmental plasticity in the T helper 17 lineage. , 2009, Immunity.

[43]  D. Jarrossay,et al.  Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.

[44]  P. Puccetti,et al.  Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans , 2009, Mucosal Immunology.

[45]  A. Fischer,et al.  Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells , 2008, The Journal of experimental medicine.

[46]  R. D. Hatton,et al.  Transforming growth factor-beta induces development of the T(H)17 lineage. , 2006, Nature.

[47]  Bodo Grimbacher,et al.  STAT3 mutations in the hyper-IgE syndrome. , 2007, The New England journal of medicine.

[48]  J. Banchereau,et al.  Influence of the transcription factor RORγt on the development of NKp46+ cell populations in gut and skin , 2009, Nature Immunology.

[49]  A. De Luca,et al.  IL‐17/Th17 in anti‐fungal immunity: What's new? , 2009, European journal of immunology.

[50]  P. Schwarzenberger,et al.  Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. , 2004, The Journal of infectious diseases.

[51]  R. Kastelein,et al.  Protective Immunity to Systemic Infection with Attenuated Salmonella enterica serovar Enteritidis in the Absence of IL-12 Is Associated with IL-23-Dependent IL-22, but Not IL-171 , 2008, The Journal of Immunology.

[52]  J. Lennerz,et al.  A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity , 2009, Nature.

[53]  W. Leonard,et al.  Cytokine mediators of Th17 function , 2009, European journal of immunology.

[54]  A. Cooper.  IL‐23 and IL‐17 have a multi‐faceted largely negative role in fungal infection , 2007, European journal of immunology.

[55]  J. Buer,et al.  The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins , 2008, Nature.

[56]  J. Renauld,et al.  Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. , 2009, Arthritis and rheumatism.

[57]  S. Khader,et al.  IL-23 and IL-17 in tuberculosis. , 2008, Cytokine.

[58]  S. Tangye,et al.  Insights into the Role of STAT3 in Human Lymphocyte Differentiation as Revealed by the Hyper-IgE Syndrome1 , 2009, The Journal of Immunology.

[59]  J. Kolls,et al.  Interleukin-17A induces bicarbonate secretion in normal human bronchial epithelial cells. , 2009, American journal of physiology. Lung cellular and molecular physiology.